Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. | Vice President - Accounting | Stock Option (Right to Buy) | 6.16K | $408K | $66.30 | Aug 2, 2021 | Direct |
Apellis Pharmaceuticals, Inc. | Vice President - Accounting | Common Stock | 4.85K | $309K | $63.69 | Aug 2, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | Aug 2, 2021 | 3 | -$60.2K | 4 | Aug 3, 2021 | Vice President - Accounting |
APLS | Apellis Pharmaceuticals, Inc. | Jul 1, 2021 | 3 | -$60.2K | 4 | Jul 2, 2021 | Vice President - Accounting |
APLS | Apellis Pharmaceuticals, Inc. | Jun 11, 2021 | 3 | -$58.4K | 4 | Jun 15, 2021 | Vice President - Accounting |
APLS | Apellis Pharmaceuticals, Inc. | Jun 1, 2021 | 3 | -$52.6K | 4 | Jun 2, 2021 | Vice President - Accounting |